PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22847887 ↗2012Reported benefit

Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.

RatIschaemia-reperfusionHepaticSprague-DawleyMaleAcute administration in the setting of ischaemia/reperfusion liver injury; fasu…

Model: Hepatic ischaemia/reperfusion injury in rats with nonalcoholic steatohepatitis

Acute sorafenib significantly attenuated hepatic inflammation, necrosis, apoptosis, leukocyte infiltration and microcirculatory dysfunction, with reduced macrophage inflammatory protein 2, keratinocyte chemoattractant and GM-CSF release, reduced caspase-3 and caspase-9 and DNA fragmentation, and de…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.